<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04924855</url>
  </required_header>
  <id_info>
    <org_study_id>UR17DN05-3</org_study_id>
    <nct_id>NCT04924855</nct_id>
  </id_info>
  <brief_title>Immunity After COVID-19 Vaccination</brief_title>
  <acronym>IACOVV</acronym>
  <official_title>Estimation of Dynamics of Humoral Immunity in COVID-19 Vaccined Health Care Workers</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>General Administration of Military Health, Tunisia</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>General Administration of Military Health, Tunisia</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the research is to evaluate kinetic after vaccination to the COVID-19&#xD;
      coronavirus by measurements of specific and neutralizant antibodies for spike antigenic&#xD;
      sequences .&#xD;
&#xD;
      This work will allow us to follow the efficacy and tolerance of the vaccine over a year, to&#xD;
      evaluate the antibody profile, their kinetics, the fraction of neutralising antibodies and&#xD;
      will also allow us to understand the attitudes to be taken to ensure the best protection for&#xD;
      our staff&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Our objective is to follow the hospital staff after vaccination, for this we will include two&#xD;
      groups of participants:&#xD;
&#xD;
      G1: vaccinated staff who did not contract the virus (at the date of vaccination) and who had&#xD;
      a serology &lt;0 at least at D7 of the date of vaccination dose 1 (known serological value) G2:&#xD;
      vaccinated personnel who have contracted the virus with a PCR + and who have positive&#xD;
      serology at least at D7 of the date of vaccination (known serological value)&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">July 2021</start_date>
  <completion_date type="Anticipated">August 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">July 1, 2022</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <target_duration>1 Year</target_duration>
  <primary_outcome>
    <measure>Vaccine effectiveness</measure>
    <time_frame>1 year</time_frame>
    <description>Vaccine effectiveness as measured by the number of positive PCRs in one year</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Vaccine effectiveness</measure>
    <time_frame>1 year</time_frame>
    <description>antibody kinetics</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>the tolerance of the vaccine</measure>
    <time_frame>1 year</time_frame>
    <description>post-vaccination adverse event</description>
  </secondary_outcome>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Tunis Military Hospital Staff Vaccinated Against Covid 19</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Blood sampling (4 per year)</intervention_name>
    <description>Blood sampling (4 per year)</description>
  </intervention>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Blood sampling (4 per year)&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        military health personnel vaccinated at tunis military hospital&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        RB-approved informed consent, age 18 years or older, male or female, anyone considering&#xD;
        COVID-19 vaccination or anyone that has received COVID-19 vaccination.&#xD;
&#xD;
        Subjects can enroll at anytime after vaccination even though they may not have enrolled&#xD;
        before vaccination.&#xD;
&#xD;
        Sampling Frequency and timing: Up to 8 total samples in 12 months -&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        Exclusion: Failure to provide informed consent&#xD;
&#xD;
        -&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
  </eligibility>
  <location>
    <facility>
      <name>HMPIT vaccination committee</name>
      <address>
        <city>Tunis</city>
        <state>Please Select...</state>
        <zip>1008</zip>
        <country>Tunisia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nejla stambouli</last_name>
      <phone>55104235</phone>
      <email>nejlastam@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Tunisia</country>
  </location_countries>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>June 10, 2021</study_first_submitted>
  <study_first_submitted_qc>June 10, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">June 14, 2021</study_first_posted>
  <last_update_submitted>June 10, 2021</last_update_submitted>
  <last_update_submitted_qc>June 10, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 14, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>COVID-19</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

